dc.creatorTorres, Cristian G.
dc.creatorOlivares, Araceli
dc.creatorStoore, Caroll
dc.date.accessioned2019-03-15T16:09:08Z
dc.date.available2019-03-15T16:09:08Z
dc.date.created2019-03-15T16:09:08Z
dc.date.issued2015
dc.identifierOncology Reports 33: 2235-2244, 2015
dc.identifier17912431
dc.identifier1021335X
dc.identifier10.3892/or.2015.3850
dc.identifierhttps://repositorio.uchile.cl/handle/2250/166427
dc.description.abstractMammary cancer is the most frequent type of tumor in the female canine. Treatments are mainly limited to surgery and chemotherapy; however, these tumors may develop clinical recurrence, metastasis and chemoresistance. The existence of a subpopulation of cancer cells with stemness features called cancer stem-like cells, may explain in part these characteristics of tumor progression. The statins, potent blockers of cholesterol synthesis, have also shown antitumor effects on cancer mammary cells, changes mediated by a decrease in the isoprenylation of specific proteins. Few studies have shown that simvastatin, a lipophilic statin, sensitizes cancer stem-like cells eliminating drug resistance. The aim of the present study was to evaluate the effects of simvastatin on spheres derived from CF41-Mg canine mammary tumor cells, which were characterized by phenotypic and functional analyses. Spheres exhibited characteristics of stemness, primarily expressing a CD44+/CD24-/low phenotype, displayi
dc.languageen
dc.publisherSpandidos Publications
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceOncology Reports
dc.subjectCanine mammary cancer
dc.subjectCD24
dc.subjectCD44
dc.subjectCF41.Mg cells
dc.subjectSimvastatin
dc.subjectSpheres
dc.titleSimvastatin exhibits antiproliferative effects on spheres derived from canine mammary carcinoma cells
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución